Targeted therapy & A2AR antagonism  ➣ BRAF inhibitor:
PLX4720 (393)
➣ MEK inhibitor:
Trametinib (393)
➣ A2AR antagonist:
SCH58261 (393)  ➣ Melanoma:
BRAFV600E-PTEN-deficient mice (393)
BRAFV600E LWT1 (393)  ➣ Primary tumor expansion rate ↓ (393)
➣ Metastasis formation ↓ (393)